News
In a new study, researchers evaluated the potential relationship between disordered eating attitudes and nutritional status ...
A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus ...
Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.
In a new letter, published in the Journal of the European Academy of Dermatology and Venereology, members of the lupus ...
A new study explores the relationship between frailty, the proportion of health deficits present in an individual, as ...
A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...
The purpose of this study is to evaluate the safety and efficacy of CNTY-101, an investigational “off-the-shelf” CD19 Chimeric Antigen Receptor (CAR) Natural Killer (NK)-cell therapy, in participants ...
When you’re living with lupus, it can impact all aspects of your daily life, including your ability to work and finances. For many, lupus symptoms like fatigue and pain can make it very difficult — or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results